Jefferies, which
raised its PT on shares of Parexel International Corp. PRXL, is providing some color on the stock.
“Parexel management discussed improving RFPs, cost reduction initiatives, and long-term margin expansion,” Jefferies writes. “The discussion gave a better understanding of the strategic relationship paradigm and impact on backlog/revenue.”
Parexel International Corp. closed Friday at $23.29.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Analyst RatingsHealth CareJefferiesLife Sciences Tools & ServicesParexel International Corp.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in